A Fascinating Molecule: Can It Reverse Age-Related Vision Loss?

Seeing clearly is not easy when the years accumulate. Even without a declared pathology, the retina becomes fragile, contrasts become dull, and darkness becomes a source of confusion. Long considered inevitable, age-related vision loss may no longer be so. A new avenue, explored by Californian researchers, calls into question this announced decline by focusing on a molecule that the body produces naturally.

An enzyme at the heart of eye aging

Vision loss almost always accompanies aging. Behind this decline, the ELOVL2 gene plays a key role. Identified by the University of California at San Diego, it acts as a marker of biological time in the retina, influencing the production of fatty acids essential for visual health. When its activity decreases, the retina loses lipids essential to the flexibility of cell membranes, which impairs the perception of contrasts and recovery in low light, two early signs of visual aging.

This gene, described as a veritable “molecular clock” of gaze, had already revealed that stimulation of its activity could restore visual performance in mice. This work inspired new research carried out by the University of California at Irvine, which focused on the direct effects of lipids produced by ELOVL2.

How Lipid Supplementation Reverses Age-Related Vision Loss

UC Irvine scientists showed that a simple injection of a very long-chain polyunsaturated fatty acid (VLC-PUFA) into the eye of aged mice improved their vision within weeks. The results, published in Science Translational Medicine, indicate that this molecule partially restores the cellular profile of a young eye.

Unlike the fatty acid DHA, often associated with eye health, this molecule allowed more marked regeneration of retinal cells. The researchers observed a drop in markers of inflammation and a better response to light. According to Dorota Skowronska-Krawczyk, co-author of the study, this approach represents initial evidence that simple lipid modulation can reverse the effects of visual aging, a major advance toward non-invasive therapies.

Towards longevity medicine for the eyes and beyond

Interest in the lipids produced by ELOVL2 goes beyond mere vision, as SciTechDaily points out. Skowronska-Krawczyk's team is now exploring the role of lipid metabolism in the aging immune system, in collaboration with the University of California, San Diego. A deficiency in ELOVL2 would accelerate the aging of immune cells, giving hope that lipid supplementation could also slow down other effects of time.

This work then opens the way to a new generation of treatments based on the restoration of natural metabolic functions. By restoring to the retina the ability to produce the right lipids at the right time, science is outlining a regenerative medicine capable not only of preserving sight, but also of delaying the signs of aging more broadly.